The Changing Face of Cancer Care
We are living in a new era of cancer care. The good news is patients are increasingly approaching their cancer care with growing emphasis on earlier intervention. Patients are coming to consultations prepared with research, questions about clinical trials, and expectations for treatments that maintain their identity and lifestyle during care.
Today’s patients have evolved mindsets, needs, and expectations – prioritizing screening and detection to wanting to know more about the root cause of their disease to having their own plan for treatment. They’re envisioning a future beyond their diagnosis, and we must be prepared to help them reach it.
At Novartis, we recognize that effective cancer care must evolve alongside the holistic needs of patients. Today’s patients expect more from their diagnosis and treatment, and we must meet them there. That is why we are committed to not only developing next-generation therapies, but also partnerships across the ecosystem to better understand the human experience, reimagine traditional treatment models and connect next generation patients to pioneering care.
– Victor Bultó, President US, Novartis